One of the projects currently under negotiations for potential acquisition and spin-off is a biotechnology firm involved in the stem cell therapy industry. The Company is currently treating patients for a large number of serious chronic diseases including ALS, Alzheimer's, Parkinsonism, multiple sclerosis, autism, post stroke, brain damage, diabetes, heart disease, advanced kidney disease, COPD etc. The Company currently treats patients both in the USA and in various international centers in Latin America. The project is currently under inital negotiations as a potential acquisition.
In addition to this deal the Company is also begining preliminary talks with several other stem cell corporations that range from start-up, research & development, and theraputic practice.